FEIBA


Also found in: Medical.
AcronymDefinition
FEIBAFactor Eight Inhibitor Bypassing Activity (freeze-dried, sterile, human plasma fraction used to aid in coagulation)
References in periodicals archive ?
Lauroua, Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors.
Reversal Agents for Oral Anticoagulant Rivaroxaban
Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors.
Terapia secuencia!; una opcion en el paciente hemofilico que no responde a! manejo con monoterapia con agentes puente, estudio observaciona! de! GrHeCol (Grupo Hemofilia Colombia)
The current guidelines recommend the use of FEIBA (activated PCC) for reversal of factor Xa inhibitors (rivaroxaban, apixaban, and edoxaban) only when the PCC fails, as activated PCC was not found to be superior to PCC for this indication, and carries a higher risk of thrombotic complications than regular PCC [27].
Reversal Strategies for Intracranial Hemorrhage Related to Direct Oral Anticoagulant Medications
Hemostatic management of surgical procedures with Feiba: a Turkish case series.
Difficulties in the treatment of an Infant with Hemophilia B
None of the factors are activated, as opposed to FEIBA. (1,5,6) It is notable that Kcentra has a higher reported range of concentration of protein C than other 4F-PCCs, which suggests a theoretical "balanced" safety profile compared to other concentrates, but this has not been proven in any study known to these authors.
Clinical Applications of 4-Factor Prothrombin Complex Concentrate: A Practical Pathologist's Perspective
FEIBA actua en su mayor parte a nivel del complejo protrombinasa convirtiendo protrombina a trombina por medio del FXa a nivel de la superficie de fosfolipidos, mien tras el rFVIIa activa al FX en las plaquetas activadas restaurando suficiente trombina para generar un coagulo estable (5, 6).
Profilaxis en pacientes con hemofilia que tienen inhibidores de alta respuesta
Other agents specifically used for bleeding episodes are FEIBA (factor VIII inhibitor bypassing activity containing activated factors VII, IX or X) or recombinant activated factor VII (3).
Acquired haemophilia in an elderly woman
[45] Baxter Healthcare Corporation, "Thrombotic and thromboembolic events following infusion of FEIBA VH or FEIBA NF," 2010, http://www.fda.gov/downloads/ biologicsbloodvaccines/safetyavailability/ucm221755.pdf.
Rivaroxaban and hemostasis in emergency care
It was reported on Friday that Baxter International, a United States-based healthcare company, has received approval for its FEIBA (Anti-Inhibitor Coagulant Complex) from the US Food and Drug Administration.
Baxter International receives approval for FEIBA
Treatment of bleeding episodes occurring in patients with acquired haemophilia with FEIBA: the French experience.
Acquired Factor VIII inhibitors: three cases / Edinsel Faktor VIII ihibitorleri: Uc Olgu
Yaygin intraabdominal kanamasi olan inhibitor gelismis hemofili A hastasinda FEIBA kullanimi.
Soft tissue bleeding in a patient with hemophilia-A/Hemofili-A'ya bagli yumusak doku kanamasi olan bir olgu
The 2 percent hike in plasma protein sales was driven by strong international demand for Feiba as well as anti-inhibitor coagulant complex, and improved domestic sales of Aralast NP (Alpha 1-Proteinase Inhibitor [Human]).
The top 30
Acronyms browser ?
Full browser ?